Exploring Regulatory T Cell Dysfunction in a Murine Model of Colitis

探索小鼠结肠炎模型中的调节性 T 细胞功能障碍

基本信息

  • 批准号:
    8415867
  • 负责人:
  • 金额:
    $ 32.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2002
  • 资助国家:
    美国
  • 起止时间:
    2002-04-05 至 2015-01-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): The overall goal of this project is to gain further understanding of the mucosal immune system and the defects that contribute to the pathogenesis of human inflammatory bowel disease (IBD). The generation of a number of murine models of IBD has facilitated investigation into the basic mechanisms underlying IBD pathogenesis. Despite the fact that many murine models of IBD result from a defect in a single protein known to affect leukocyte function, the specific auto-reactive and/or regulatory cell population responsible for disease pathogenesis in these models remains unknown. We recently generated a mouse model of IBD that results from the targeted disruption of the Wiskott-Aldrich syndrome protein (WASP). WASP is expressed solely in hematopoietic cells and is a signaling molecule that regulates cell surface receptor signals to the cytoskeleton. Abnormalities in this protein lead to the rare X-linked primary immunodeficiency that carries its name. Autoimmunity is commonly associated with this immunodeficiency, and up to 10 percent of patients develop an IBD-like illness. Our lab has recently shown that 100% of WASP KO (WKO) mice also develop colitis. Genetic and adoptive transfer studies have shown that lymphocytes are essential and CD4+ lymphocytes are sufficient for colitis development. In contrast with most murine models of IBD that have a Th1 bias, we have demonstrated a Th2 cytokine skewing (with elevated IL-4 and IL-13) in lamina propria (LP) lymphocytes and in tissues. Indeed, IL-4 is required, at least in part, for colitis development. Perhaps, most interestingly, we have recently shown that there is marked reduction in the development and function of regulatory T cells in WKO animals. Our overall hypothesis is that the colitis in WKO mice results from both intrinsic Treg dysfunction as well as extrinsic signaling/cytokine abnormalities within the CD4+ T cell/APC population that results in Treg dysfunction. In this proposal we seek to determine the cellular and molecular basis for colitis development and autoimmunity in WKO mice. Aim 1 seeks to uncover the mechanism(s) (development, migration, and cell-cell contacts) that are responsible for the aberrant Treg development and dysfunction in WKO mice. Aim 2 seeks to assess the impact of WASP deficiency in innate immune cells on the generation and function of Tregs. Aim 3 seeks to determine the role of WASP-dependant T cell receptor (TCR) signaling and aberrant cytokine secretion on Treg dysfunction. The overall goal of this proposal is to further our understanding of the mechanism of colitis in WKO mice that is uniquely associated with both profound regulatory T cell defects and Th2 cytokine skewing and to take advantage of a murine model of colitis that uniquely has a human correlate. Our driving premise is that such knowledge will not only aid in the understanding and treatment of the debilitating autoimmunity (and IBD-like illness) that characterizes the human immunodeficiency but will also aid in our understanding of mucosal immune regulation in general and the molecular underpinnings of inflammatory bowel disease.
描述(由申请人提供):该项目的总体目标是进一步了解粘膜免疫系统以及导致人类炎症性肠病(IBD)发病机制的缺陷。许多IBD小鼠模型的产生促进了对IBD发病机制的基本机制的研究。尽管许多 IBD 小鼠模型是由已知影响白细胞功能的单一蛋白质缺陷引起的,但在这些模型中负责疾病发病机制的特定自身反应和/或调节细胞群仍然未知。我们最近建立了一种 IBD 小鼠模型,该模型是由 Wiskott-Aldrich 综合征蛋白 (WASP) 的靶向破坏引起的。 WASP 仅在造血细胞中表达,是调节细胞表面受体向细胞骨架发出信号的信号分子。这种蛋白质的异常会导致罕见的 X 连锁原发性免疫缺陷病,该病也因此得名。自身免疫通常与这种免疫缺陷有关,高达 10% 的患者会出现类似 IBD 的疾病。我们的实验室最近表明,100% 的 WASP KO (WKO) 小鼠也会患上结肠炎。遗传和过继转移研究表明,淋巴细胞对于结肠炎的发展至关重要,并且 CD4+ 淋巴细胞足以形成结肠炎。与大多数具有 Th1 偏好的 IBD 小鼠模型相比,我们在固有层 (LP) 淋巴细胞和组织中证明了 Th2 细胞因子偏向(IL-4 和 IL-13 升高)。事实上,IL-4 是结肠炎发展所必需的,至少是部分必需的。也许,最有趣的是,我们最近发现 WKO 动物中调节性 T 细胞的发育和功能显着减少。我们的总体假设是,WKO 小鼠的结肠炎是由内在 Treg 功能障碍以及 CD4+ T 细胞/APC 群体内导致 Treg 功能障碍的外在信号/细胞因子异常引起的。在本提案中,我们试图确定 WKO 小鼠结肠炎发展和自身免疫的细胞和分子基础。目标 1 试图揭示导致 WKO 小鼠 Treg 异常发育和功能障碍的机制(发育、迁移和细胞间接触)。目标 2 旨在评估先天免疫细胞中 WASP 缺陷对 Tregs 的生成和功能的影响。目标 3 旨在确定 WASP 依赖性 T 细胞受体 (TCR) 信号传导和异常细胞因子分泌对 Treg 功能障碍的作用。该提案的总体目标是进一步了解 WKO 小鼠结肠炎的机制,该机制与深度调节性 T 细胞缺陷和 Th2 细胞因子偏差独特相关,并利用与人类独特相关的小鼠结肠炎模型。我们的驱动前提是,这些知识不仅有助于理解和治疗人类免疫缺陷所特有的衰弱性自身免疫(和炎症性肠病样疾病),而且还有助于我们了解粘膜免疫调节的一般情况和分子基础。炎症性肠病。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Inflammatory bowel disease and mutations affecting the interleukin-10 receptor.
  • DOI:
    10.1056/nejmoa0907206
  • 发表时间:
    2009-11-19
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Glocker EO;Kotlarz D;Boztug K;Gertz EM;Schäffer AA;Noyan F;Perro M;Diestelhorst J;Allroth A;Murugan D;Hätscher N;Pfeifer D;Sykora KW;Sauer M;Kreipe H;Lacher M;Nustede R;Woellner C;Baumann U;Salzer U;Koletzko S;Shah N;Segal AW;Sauerbrey A;Buderus S;Snapper SB;Grimbacher B;Klein C
  • 通讯作者:
    Klein C
Variants in TRIM22 That Affect NOD2 Signaling Are Associated With Very-Early-Onset Inflammatory Bowel Disease.
  • DOI:
    10.1053/j.gastro.2016.01.031
  • 发表时间:
    2016-05
  • 期刊:
  • 影响因子:
    29.4
  • 作者:
    Li Q;Lee CH;Peters LA;Mastropaolo LA;Thoeni C;Elkadri A;Schwerd T;Zhu J;Zhang B;Zhao Y;Hao K;Dinarzo A;Hoffman G;Kidd BA;Murchie R;Al Adham Z;Guo C;Kotlarz D;Cutz E;Walters TD;Shouval DS;Curran M;Dobrin R;Brodmerkel C;Snapper SB;Klein C;Brumell JH;Hu M;Nanan R;Snanter-Nanan B;Wong M;Le Deist F;Haddad E;Roifman CM;Deslandres C;Griffiths AM;Gaskin KJ;Uhlig HH;Schadt EE;Muise AM
  • 通讯作者:
    Muise AM
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Scott B Snapper其他文献

Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
抗肿瘤坏死因子α在极早发炎症性肠病中的功效和安全性。
  • DOI:
    10.1093/ibd/izad196
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    4.9
  • 作者:
    L. Collen;V. Mitsialis;David Y. Kim;Mairead Bresnahan;Jessica Yang;M. Tuthill;A. Combs;J. Barends;M. Field;Enju Liu;R. Bearup;I. Okoroafor;Christoph Klein;A. Muise;A. Bousvaros;J. Ouahed;Scott B Snapper
  • 通讯作者:
    Scott B Snapper
Discordance between a deep learning model and clinical-grade variant pathogenicity classification in a rare disease cohort
罕见疾病队列中深度学习模型与临床级变异致病性分类之间的不一致
  • DOI:
    10.1101/2024.05.22.24307756
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    S. Kong;In;Lauren V Collen;Arjun K Manrai;Scott B Snapper;Kenneth D Mandl
  • 通讯作者:
    Kenneth D Mandl

Scott B Snapper的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Scott B Snapper', 18)}}的其他基金

Employing novel humanized murine strains to develop hematopoietic stem cell gene therapeutic approaches for very early-onset inflammatory bowel disease due to IL10-receptor deficiency.
采用新型人源化小鼠品系开发造血干细胞基因治疗方法,用于治疗因 IL10 受体缺陷所致的极早发炎症性肠病。
  • 批准号:
    9535567
  • 财政年份:
    2017
  • 资助金额:
    $ 32.38万
  • 项目类别:
Type III interferon Control of Mucosal Immunity
III 型干扰素控制粘膜免疫
  • 批准号:
    10587625
  • 财政年份:
    2017
  • 资助金额:
    $ 32.38万
  • 项目类别:
Exploring Regulatory T Cell Dysfunction in a Murine Model of Colitis
探索小鼠结肠炎模型中的调节性 T 细胞功能障碍
  • 批准号:
    8232674
  • 财政年份:
    2011
  • 资助金额:
    $ 32.38万
  • 项目类别:
Deciphering the Role of WASP Family Proteins in T Cell Function
解读 WASP 家族蛋白在 T 细胞功能中的作用
  • 批准号:
    8147996
  • 财政年份:
    2010
  • 资助金额:
    $ 32.38万
  • 项目类别:
Exploring Regulatory T Cell Dysfunction in a Murine Model of Colitis
探索小鼠结肠炎模型中的调节性 T 细胞功能障碍
  • 批准号:
    7877475
  • 财政年份:
    2009
  • 资助金额:
    $ 32.38万
  • 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
  • 批准号:
    6800508
  • 财政年份:
    2003
  • 资助金额:
    $ 32.38万
  • 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
  • 批准号:
    6833455
  • 财政年份:
    2003
  • 资助金额:
    $ 32.38万
  • 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
  • 批准号:
    7161772
  • 财政年份:
    2003
  • 资助金额:
    $ 32.38万
  • 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
  • 批准号:
    6630241
  • 财政年份:
    2003
  • 资助金额:
    $ 32.38万
  • 项目类别:
Cytoskeletal-Pathogen Interactions in Shigella Infection
志贺氏菌感染中的细胞骨架-病原体相互作用
  • 批准号:
    7012813
  • 财政年份:
    2003
  • 资助金额:
    $ 32.38万
  • 项目类别:

相似国自然基金

十年禁渔对赤水河底栖动物群落多样性及其维持机制的影响
  • 批准号:
    32301370
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
模拟增温对高寒草甸节肢动物“晨起”时间的影响及其生态学效应
  • 批准号:
    32301391
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
三江源国家公园黄河源园区食草野生动物与放牧家畜冲突的强度、影响及未来情景
  • 批准号:
    42371283
  • 批准年份:
    2023
  • 资助金额:
    46 万元
  • 项目类别:
    面上项目
城市化对土壤动物宿主-寄生虫关系的影响机制研究
  • 批准号:
    32301430
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
大型野生动物对秦岭山地森林林下植物物种组成和多样性的影响及作用机制
  • 批准号:
    32371605
  • 批准年份:
    2023
  • 资助金额:
    50 万元
  • 项目类别:
    面上项目

相似海外基金

Salt Mediated Cross Talk Between Lymphatic Vessels and Immune Cells in Kidney Disease
盐介导肾脏疾病中淋巴管和免疫细胞之间的交互作用
  • 批准号:
    10636755
  • 财政年份:
    2023
  • 资助金额:
    $ 32.38万
  • 项目类别:
The role of SH2B3 in regulating CD8 T cells in Type 1 Diabetes
SH2B3 在 1 型糖尿病中调节 CD8 T 细胞的作用
  • 批准号:
    10574346
  • 财政年份:
    2023
  • 资助金额:
    $ 32.38万
  • 项目类别:
Role of TLR7-mediated B cell activation in primary Sjogren’s syndrome
TLR7 介导的 B 细胞激活在原发性干燥综合征中的作用
  • 批准号:
    10676443
  • 财政年份:
    2023
  • 资助金额:
    $ 32.38万
  • 项目类别:
Immunotherapy for Synucleinopathies: Can Gut Microbiota Affect Efficacy?
突触核蛋白病的免疫疗法:肠道微生物群会影响疗效吗?
  • 批准号:
    10666872
  • 财政年份:
    2023
  • 资助金额:
    $ 32.38万
  • 项目类别:
Non-tuberculous mycobacterium and B cells in the stimulation of ectopic germinal centers and immunological control of pulmonary tuberculosis
非结核分枝杆菌和 B 细胞在异位生发中心刺激和肺结核免疫控制中的作用
  • 批准号:
    10569865
  • 财政年份:
    2023
  • 资助金额:
    $ 32.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了